A Real-World Evidence Study Assessing the Impact of Adding the Aerobika Oscillating Positive Expiratory Pressure Device to Standard of Care ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-06-01

AUTHORS

Chakkarin Burudpakdee, Aimee M. Near, Huan Huang, Dominic Coppolo, Vladimir Kushnarev, Jason Suggett

ABSTRACT

IntroductionThe aim of this real-world study was to measure the benefit of the Aerobika oscillating positive expiratory pressure (OPEP) device when added to standard of care (defined as incentive spirometry [IS]) for post-operative patients.MethodsAdults aged ≥ 18 years who were hospitalized for cardiac, thoracic or upper abdominal surgery between 1 September 2013 and 30 April 2017 were identified from IQVIA’s Hospital Charge Detail Master (CDM) database; the index date was the date of the first hospitalization for surgery. The control cohort (IS) included patients who had ≥ 1 CDM record within 12 months prior to the index date and ≥ 1 record after discharge, evidence of IS use during index hospitalization and no evidence of use of a PEP or OPEP device at any time during the study period. The Aerobika OPEP cohort was selected in a similar manner, except that patients were required to have evidence of Aerobika OPEP use during the index hospitalization. Aerobika OPEP patients were 1:1 matched to IS patients using propensity score (PS) matching. Hospital readmissions and costs were measured at 30 days post-discharge from the index hospitalization.ResultsAfter PS matching, 144 patients were included in each cohort. At 30 days post-discharge, compared to the control (IS) cohort there were significantly fewer patients in the Aerobika OPEP cohort with ≥ 1 all-cause re-hospitalizations (13.9 vs. 22.9%; p = 0.042). The patients in the Aerobika OPEP cohort also had a shorter mean length of stay (± standard deviation) (1.25 ± 4.04 vs. 2.60 ± 8.24 days; p = 0.047) and lower total unadjusted mean all-cause cost per patient ($3670 ± $13,894 vs. $13,775 ± $84,238; p = 0.057). Adjusted analyses suggested that hospitalization costs were 80% lower for the Aerobika OPEP cohort versus the IS cohort (p = 0.001).ConclusionOur results suggest that the addition of the Aerobika OPEP device to standard of care (IS) is beneficial in the post-operative setting.FundingTrudell Medical International. More... »

PAGES

87-101

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s41030-018-0055-9

DOI

http://dx.doi.org/10.1007/s41030-018-0055-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104016752

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32026246


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "IQVIA, Fairfax, VA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "IQVIA, Fairfax, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burudpakdee", 
        "givenName": "Chakkarin", 
        "id": "sg:person.0676207263.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676207263.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IQVIA, Fairfax, VA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "IQVIA, Fairfax, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Near", 
        "givenName": "Aimee M.", 
        "id": "sg:person.0677153660.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677153660.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IQVIA, Fairfax, VA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "IQVIA, Fairfax, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "Huan", 
        "id": "sg:person.010551324656.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010551324656.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Monaghan Medical Corporation, Syracuse, NY, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Monaghan Medical Corporation, Syracuse, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coppolo", 
        "givenName": "Dominic", 
        "id": "sg:person.0637172033.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637172033.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Trudell Medical International, London, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.417314.4", 
          "name": [
            "Trudell Medical International, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kushnarev", 
        "givenName": "Vladimir", 
        "id": "sg:person.012530273622.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012530273622.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Trudell Medical International, London, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.417314.4", 
          "name": [
            "Trudell Medical International, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suggett", 
        "givenName": "Jason", 
        "id": "sg:person.01162470550.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162470550.76"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf02602761", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035181937", 
          "https://doi.org/10.1007/bf02602761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s41030-017-0027-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083696496", 
          "https://doi.org/10.1007/s41030-017-0027-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc8442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027393069", 
          "https://doi.org/10.1186/cc8442"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-06-01", 
    "datePublishedReg": "2018-06-01", 
    "description": "IntroductionThe aim of this real-world study was to measure the benefit of the Aerobika oscillating positive expiratory pressure (OPEP) device when added to standard of care (defined as incentive spirometry [IS]) for post-operative patients.MethodsAdults aged\u2009\u2265\u200918\u00a0years who were hospitalized for cardiac, thoracic or upper abdominal surgery between 1 September 2013 and 30 April 2017 were identified from IQVIA\u2019s Hospital Charge Detail Master (CDM) database; the index date was the date of the first hospitalization for surgery. The control cohort (IS) included patients who had\u2009\u2265\u20091 CDM record within 12\u00a0months prior to the index date and\u2009\u2265\u20091 record after discharge, evidence of IS use during index hospitalization and no evidence of use of a PEP or OPEP device at any time during the study period. The Aerobika OPEP cohort was selected in a similar manner, except that patients were required to have evidence of Aerobika OPEP use during the index hospitalization. Aerobika OPEP patients were 1:1 matched to IS patients using propensity score (PS) matching. Hospital readmissions and costs were measured at 30\u00a0days post-discharge from the index hospitalization.ResultsAfter PS matching, 144 patients were included in each cohort. At 30\u00a0days post-discharge, compared to the control (IS) cohort there were significantly fewer patients in the Aerobika OPEP cohort with\u2009\u2265\u20091 all-cause re-hospitalizations (13.9 vs. 22.9%;  p\u2009=\u20090.042). The patients in the Aerobika OPEP cohort also had a shorter mean length of stay (\u00b1\u2009standard deviation) (1.25\u2009\u00b1\u20094.04 vs. 2.60\u2009\u00b1\u20098.24\u00a0days; p\u2009=\u20090.047) and lower total unadjusted mean all-cause cost per patient ($3670\u2009\u00b1\u2009$13,894 vs. $13,775\u2009\u00b1\u2009$84,238; p\u2009=\u20090.057). Adjusted analyses suggested that hospitalization costs were 80% lower for the Aerobika OPEP cohort versus the IS cohort (p\u2009=\u20090.001).ConclusionOur results suggest that the addition of the Aerobika OPEP device to standard of care (IS) is beneficial in the post-operative setting.FundingTrudell Medical International.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s41030-018-0055-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1136859", 
        "issn": [
          "2364-1754", 
          "2364-1746"
        ], 
        "name": "Pulmonary Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "keywords": [
      "oscillating positive expiratory pressure device", 
      "standard of care", 
      "post-operative patients", 
      "positive expiratory pressure device", 
      "index hospitalization", 
      "index date", 
      "control cohort", 
      "real-world evidence study", 
      "post-operative setting", 
      "upper abdominal surgery", 
      "pressure device", 
      "healthcare resource utilization", 
      "shorter mean length", 
      "real-world study", 
      "OPEP devices", 
      "abdominal surgery", 
      "first hospitalization", 
      "hospital readmission", 
      "adjusted analysis", 
      "hospitalization costs", 
      "cause costs", 
      "IS cohort", 
      "IntroductionThe aim", 
      "patients", 
      "PS matching", 
      "evidence studies", 
      "hospitalization", 
      "cohort", 
      "Propensity Score Matching", 
      "ConclusionOur results", 
      "study period", 
      "mean length", 
      "care", 
      "surgery", 
      "Score Matching", 
      "days", 
      "readmission", 
      "evidence", 
      "stay", 
      "thoracic", 
      "months", 
      "evidence of use", 
      "Aged", 
      "date", 
      "records", 
      "study", 
      "cause", 
      "similar manner", 
      "resource utilization", 
      "use", 
      "aim", 
      "years", 
      "setting", 
      "period", 
      "discharge", 
      "standards", 
      "benefits", 
      "database", 
      "manner", 
      "master database", 
      "IS use", 
      "addition", 
      "PEP", 
      "utilization", 
      "time", 
      "impact", 
      "cost", 
      "length", 
      "results", 
      "analysis", 
      "devices", 
      "matching", 
      "Aerobika oscillating positive expiratory pressure (OPEP) device", 
      "expiratory pressure (OPEP) device", 
      "MethodsAdults aged", 
      "IQVIA\u2019s Hospital Charge Detail Master (CDM) database", 
      "\u2019s Hospital Charge Detail Master (CDM) database", 
      "Charge Detail Master (CDM) database", 
      "Detail Master (CDM) database", 
      "CDM record", 
      "Aerobika OPEP cohort", 
      "OPEP cohort", 
      "Aerobika OPEP use", 
      "OPEP use", 
      "Aerobika OPEP patients", 
      "OPEP patients", 
      "ResultsAfter PS matching", 
      "Aerobika OPEP device"
    ], 
    "name": "A Real-World Evidence Study Assessing the Impact of Adding the Aerobika Oscillating Positive Expiratory Pressure Device to Standard of Care Upon Healthcare Resource Utilization and Costs in Post-Operative Patients", 
    "pagination": "87-101", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104016752"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s41030-018-0055-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32026246"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s41030-018-0055-9", 
      "https://app.dimensions.ai/details/publication/pub.1104016752"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_759.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s41030-018-0055-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s41030-018-0055-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s41030-018-0055-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s41030-018-0055-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s41030-018-0055-9'


 

This table displays all metadata directly associated to this object as RDF triples.

202 TRIPLES      22 PREDICATES      117 URIs      106 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s41030-018-0055-9 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Ne1e6b8a56fac46c2a108e61549970e4f
4 schema:citation sg:pub.10.1007/bf02602761
5 sg:pub.10.1007/s41030-017-0027-5
6 sg:pub.10.1186/cc8442
7 schema:datePublished 2018-06-01
8 schema:datePublishedReg 2018-06-01
9 schema:description IntroductionThe aim of this real-world study was to measure the benefit of the Aerobika oscillating positive expiratory pressure (OPEP) device when added to standard of care (defined as incentive spirometry [IS]) for post-operative patients.MethodsAdults aged ≥ 18 years who were hospitalized for cardiac, thoracic or upper abdominal surgery between 1 September 2013 and 30 April 2017 were identified from IQVIA’s Hospital Charge Detail Master (CDM) database; the index date was the date of the first hospitalization for surgery. The control cohort (IS) included patients who had ≥ 1 CDM record within 12 months prior to the index date and ≥ 1 record after discharge, evidence of IS use during index hospitalization and no evidence of use of a PEP or OPEP device at any time during the study period. The Aerobika OPEP cohort was selected in a similar manner, except that patients were required to have evidence of Aerobika OPEP use during the index hospitalization. Aerobika OPEP patients were 1:1 matched to IS patients using propensity score (PS) matching. Hospital readmissions and costs were measured at 30 days post-discharge from the index hospitalization.ResultsAfter PS matching, 144 patients were included in each cohort. At 30 days post-discharge, compared to the control (IS) cohort there were significantly fewer patients in the Aerobika OPEP cohort with ≥ 1 all-cause re-hospitalizations (13.9 vs. 22.9%; p = 0.042). The patients in the Aerobika OPEP cohort also had a shorter mean length of stay (± standard deviation) (1.25 ± 4.04 vs. 2.60 ± 8.24 days; p = 0.047) and lower total unadjusted mean all-cause cost per patient ($3670 ± $13,894 vs. $13,775 ± $84,238; p = 0.057). Adjusted analyses suggested that hospitalization costs were 80% lower for the Aerobika OPEP cohort versus the IS cohort (p = 0.001).ConclusionOur results suggest that the addition of the Aerobika OPEP device to standard of care (IS) is beneficial in the post-operative setting.FundingTrudell Medical International.
10 schema:genre article
11 schema:inLanguage en
12 schema:isAccessibleForFree true
13 schema:isPartOf N8df0ca6680b542ccb4513eb79fd780c2
14 Nac232610dc614c48b565c625777bd0a5
15 sg:journal.1136859
16 schema:keywords Aerobika OPEP cohort
17 Aerobika OPEP device
18 Aerobika OPEP patients
19 Aerobika OPEP use
20 Aerobika oscillating positive expiratory pressure (OPEP) device
21 Aged
22 CDM record
23 Charge Detail Master (CDM) database
24 ConclusionOur results
25 Detail Master (CDM) database
26 IQVIA’s Hospital Charge Detail Master (CDM) database
27 IS cohort
28 IS use
29 IntroductionThe aim
30 MethodsAdults aged
31 OPEP cohort
32 OPEP devices
33 OPEP patients
34 OPEP use
35 PEP
36 PS matching
37 Propensity Score Matching
38 ResultsAfter PS matching
39 Score Matching
40 abdominal surgery
41 addition
42 adjusted analysis
43 aim
44 analysis
45 benefits
46 care
47 cause
48 cause costs
49 cohort
50 control cohort
51 cost
52 database
53 date
54 days
55 devices
56 discharge
57 evidence
58 evidence of use
59 evidence studies
60 expiratory pressure (OPEP) device
61 first hospitalization
62 healthcare resource utilization
63 hospital readmission
64 hospitalization
65 hospitalization costs
66 impact
67 index date
68 index hospitalization
69 length
70 manner
71 master database
72 matching
73 mean length
74 months
75 oscillating positive expiratory pressure device
76 patients
77 period
78 positive expiratory pressure device
79 post-operative patients
80 post-operative setting
81 pressure device
82 readmission
83 real-world evidence study
84 real-world study
85 records
86 resource utilization
87 results
88 setting
89 shorter mean length
90 similar manner
91 standard of care
92 standards
93 stay
94 study
95 study period
96 surgery
97 thoracic
98 time
99 upper abdominal surgery
100 use
101 utilization
102 years
103 ’s Hospital Charge Detail Master (CDM) database
104 schema:name A Real-World Evidence Study Assessing the Impact of Adding the Aerobika Oscillating Positive Expiratory Pressure Device to Standard of Care Upon Healthcare Resource Utilization and Costs in Post-Operative Patients
105 schema:pagination 87-101
106 schema:productId N13a93fa005154ce38e8bbd05095931f5
107 N1b0402e8492d4c67ab960d1676e8d119
108 Nbc233331bb6a40b694facab4ff2110a0
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104016752
110 https://doi.org/10.1007/s41030-018-0055-9
111 schema:sdDatePublished 2021-11-01T18:32
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N818072d2b2774d5ea65d1069c78001fa
114 schema:url https://doi.org/10.1007/s41030-018-0055-9
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N13a93fa005154ce38e8bbd05095931f5 schema:name pubmed_id
119 schema:value 32026246
120 rdf:type schema:PropertyValue
121 N1b0402e8492d4c67ab960d1676e8d119 schema:name doi
122 schema:value 10.1007/s41030-018-0055-9
123 rdf:type schema:PropertyValue
124 N570a2f57464f461ba17a7aed44c01f24 rdf:first sg:person.012530273622.57
125 rdf:rest Ne74a44c9986a40b2a1be3703b1ff27d7
126 N818072d2b2774d5ea65d1069c78001fa schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 N8df0ca6680b542ccb4513eb79fd780c2 schema:issueNumber 1
129 rdf:type schema:PublicationIssue
130 Na82b3a1a311b408cb939ddb9f582fddc rdf:first sg:person.010551324656.52
131 rdf:rest Nebf7200ac701452ebb238a8040314af2
132 Nac232610dc614c48b565c625777bd0a5 schema:volumeNumber 4
133 rdf:type schema:PublicationVolume
134 Nae2330d9073044e2bde2cb8fc6278d38 rdf:first sg:person.0677153660.14
135 rdf:rest Na82b3a1a311b408cb939ddb9f582fddc
136 Nbc233331bb6a40b694facab4ff2110a0 schema:name dimensions_id
137 schema:value pub.1104016752
138 rdf:type schema:PropertyValue
139 Ne1e6b8a56fac46c2a108e61549970e4f rdf:first sg:person.0676207263.14
140 rdf:rest Nae2330d9073044e2bde2cb8fc6278d38
141 Ne74a44c9986a40b2a1be3703b1ff27d7 rdf:first sg:person.01162470550.76
142 rdf:rest rdf:nil
143 Nebf7200ac701452ebb238a8040314af2 rdf:first sg:person.0637172033.32
144 rdf:rest N570a2f57464f461ba17a7aed44c01f24
145 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
146 schema:name Medical and Health Sciences
147 rdf:type schema:DefinedTerm
148 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
149 schema:name Cardiorespiratory Medicine and Haematology
150 rdf:type schema:DefinedTerm
151 sg:journal.1136859 schema:issn 2364-1746
152 2364-1754
153 schema:name Pulmonary Therapy
154 schema:publisher Springer Nature
155 rdf:type schema:Periodical
156 sg:person.010551324656.52 schema:affiliation grid-institutes:None
157 schema:familyName Huang
158 schema:givenName Huan
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010551324656.52
160 rdf:type schema:Person
161 sg:person.01162470550.76 schema:affiliation grid-institutes:grid.417314.4
162 schema:familyName Suggett
163 schema:givenName Jason
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162470550.76
165 rdf:type schema:Person
166 sg:person.012530273622.57 schema:affiliation grid-institutes:grid.417314.4
167 schema:familyName Kushnarev
168 schema:givenName Vladimir
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012530273622.57
170 rdf:type schema:Person
171 sg:person.0637172033.32 schema:affiliation grid-institutes:None
172 schema:familyName Coppolo
173 schema:givenName Dominic
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637172033.32
175 rdf:type schema:Person
176 sg:person.0676207263.14 schema:affiliation grid-institutes:None
177 schema:familyName Burudpakdee
178 schema:givenName Chakkarin
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676207263.14
180 rdf:type schema:Person
181 sg:person.0677153660.14 schema:affiliation grid-institutes:None
182 schema:familyName Near
183 schema:givenName Aimee M.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677153660.14
185 rdf:type schema:Person
186 sg:pub.10.1007/bf02602761 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035181937
187 https://doi.org/10.1007/bf02602761
188 rdf:type schema:CreativeWork
189 sg:pub.10.1007/s41030-017-0027-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083696496
190 https://doi.org/10.1007/s41030-017-0027-5
191 rdf:type schema:CreativeWork
192 sg:pub.10.1186/cc8442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027393069
193 https://doi.org/10.1186/cc8442
194 rdf:type schema:CreativeWork
195 grid-institutes:None schema:alternateName IQVIA, Fairfax, VA, USA
196 Monaghan Medical Corporation, Syracuse, NY, USA
197 schema:name IQVIA, Fairfax, VA, USA
198 Monaghan Medical Corporation, Syracuse, NY, USA
199 rdf:type schema:Organization
200 grid-institutes:grid.417314.4 schema:alternateName Trudell Medical International, London, ON, Canada
201 schema:name Trudell Medical International, London, ON, Canada
202 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...